Busulfan Safety Questions, Busulfan Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Busulfan side effects. Check out Health Surveys and Health Polls. If you have questions about Busulfan, you can post them to our Doctors or Ask Patient Community about Busulfan.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Busulfan
Busulfan Safety Reports
Total Busulfan reports: 112.Busulfan FDA safety alerts: No.
Reported deaths: 42 Reported hospitalizations: 44.
Take Busulfan Side Effects Survey or Share Your Busulfan Story.
Reported Busulfan Side Effects: diarrhoea, sepsis, anorexia, acute graft versus host disease, venoocclusive liver disease, malaise, graft versus host disease, stomatitis, stem cell transplant, nausea, liver disorder.
More About Busulfan.
Showing 1-50 of 112 Next >
Busulfan Side Effects Report #5356576-3Health Professional from JAPAN reported BUSULFAN problem on May 29, 2007. Female patient, 54 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, depressed level of consciousness, graft versus host disease, inappropriate antidiuretic hormone secretion, malaise, nausea, sepsis, stem cell transplant, thrombotic microangiopathy. BUSULFAN dosage: unknown. During the same period patient was treated with NEUPOGEN, NEUTROGIN, IMATINIB MESYLATE, VALPROATE, CYCLOPHOSPHAMIDE, METHOTREXATE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5356577-5
BUSULFAN problem was reported by a Health Professional from JAPAN on May 29, 2007. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, nausea, oedema, pneumonia, sepsis, venoocclusive liver disease. BUSULFAN dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.
Busulfan Side Effects Report #5363111-2
Consumer or non-health professional from JAPAN reported BUSULFAN problem on June 01, 2007. Female patient, 21 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, multi-organ failure, neutrophil count decreased, staphylococcal sepsis. BUSULFAN dosage: unknown. During the same period patient was treated with PHENYTOIN, CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient died on 05/05/2007.
Busulfan Side Effects Report #5363112-4
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on May 31, 2007. Male patient, 47 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: coagulation factor xiii level decreased, disease progression, human t-cell lymphotropic virus type i infection, mallory-weiss syndrome, stem cell transplant. BUSULFAN dosage: unknown. Patient recovered.
Busulfan Side Effects Report #5363113-6
Consumer or non-health professional from JAPAN reported BUSULFAN problem on June 01, 2007. Female patient, 48 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood bilirubin increased, bone marrow transplant, cardiac failure, engraftment syndrome, haematemesis, hepatic function abnormal, infusion related reaction, interstitial lung disease. BUSULFAN dosage: 5.3 ML; QID; IV. During the same period patient was treated with HEPARIN, CYCLOPHOSPHAMIDE, PHENYTOIN. Patient recovered.
Busulfan Side Effects Report #5369351-0
BUSULFAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 05, 2007. Male patient, 51 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: hepatobiliary disease, sarcoidosis. BUSULFAN dosage: unknown. During the same period patient was treated with CAMPATH, FLUDARABINE PHOSPHATE, LANSOPRAZOLE, PENICILLIN V. Patient recovered.
Busulfan Side Effects Report #5369362-5
Consumer or non-health professional from JAPAN reported BUSULFAN problem on June 08, 2007. Female patient, child 2 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, febrile neutropenia, herpes zoster, interstitial lung disease, malaise, nausea, vomiting. BUSULFAN dosage: 1.2 MG/KG; QID; IV. During the same period patient was treated with FILGRASTIM, CYCLOSPORINE, CYCLOPHOSPHAMIDE. Patient died on 03/19/2007.
Busulfan Side Effects Report #5369891-4
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on June 07, 2007. Male patient, 52 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, cytomegalovirus antigen positive, diarrhoea, dysuria, erythema, graft versus host disease, interstitial lung disease, liver disorder, malaise. BUSULFAN dosage: 7.7 ML; QID; IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS, PHENYTOIN, METHOTREXATE, GRANISETRON. Patient died on 04/22/2007.
Busulfan Side Effects Report #5369892-6
Consumer or non-health professional from JAPAN reported BUSULFAN problem on June 07, 2007. Male patient, 40 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, bone marrow transplant rejection, peritonitis, tumour lysis syndrome, venoocclusive liver disease. BUSULFAN dosage: 216 MG; QD; IV. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5374098-0
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on June 18, 2007. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cerebral haemorrhage, convulsion, haematoma, hypothalamo-pituitary disorder, mitral valve incompetence, nausea, oedema, pneumonia. BUSULFAN dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.
Busulfan Side Effects Report #5046587-X
Consumer or non-health professional from UNITED STATES reported BUSULFAN problem on July 05, 2006. Female patient, weighting 159.6 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, dysuria, epistaxis, faeces discoloured, fatigue, haemoglobin decreased, platelet count decreased. BUSULFAN dosage: 12.8 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, DAUNORUBICIN, GEMTUZMAB OZOGAMICIN. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5059934-X
BUSULFAN problem was reported by a Consumer or non-health professional from FRANCE on July 04, 2006. Male patient, 44 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: aplasia, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, incorrect dose administered, mucosal inflammation, overdose, stomatitis, transaminases increased. BUSULFAN dosage: 208 MG; QD; IV. During the same period patient was treated with ALKERAN. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5082672-4
Consumer or non-health professional from UNITED STATES reported BUSULFAN problem on Aug 16, 2006. Female patient, weighting 160.9 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, diffuse alveolar damage, disseminated intravascular coagulation, gamma-glutamyltransferase increased, haemorrhage, hyperglycaemia, hypoxia, renal failure, sepsis. BUSULFAN dosage: 1.6 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5091195-8
BUSULFAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 25, 2006. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant. BUSULFAN dosage: 1270 MG. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5108881-3
Health Professional from UNITED STATES reported BUSULFAN problem on Sept 15, 2006. Male patient, 55 years of age, weighting 191.6 lb, was diagnosed with acute myeloid leukaemia and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: amnesia, blood bilirubin abnormal, gastrointestinal haemorrhage, graft versus host disease, post procedural complication. BUSULFAN dosage: 50 MG /PO. During the same period patient was treated with BUSULFAN MUD TRANSPLANT, CYTOXAN, TACROLIMUS, METHYLPREDNISOLONE, REMICADE, TRIAMCINOLONE, DESONIDE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5108904-1
BUSULFAN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2006. Male patient, weighting 138.2 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, dyspnoea, hypoxia, pneumothorax, stem cell transplant. BUSULFAN dosage: 408 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5122933-3
Health Professional from UNITED STATES reported BUSULFAN problem on Oct 05, 2006. Male patient, 55 years of age, weighting 202.2 lb, was diagnosed with acute myeloid leukaemia and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites, blood bilirubin abnormal, oedema, stem cell transplant. BUSULFAN dosage: 50 MG/PO. During the same period patient was treated with BUSULFAN MUD TRANSPLANT, CYTOXAN, ESOMEPRAZOLE MAGNESIUM, DIPHENHYDRAMINE, HYDROMORPONE. Patient was hospitalized. Patient died.
Busulfan Side Effects Report #5153301-6
BUSULFAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2006. Male patient, weighting 138.2 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, diffuse alveolar damage, oxygen saturation decreased, pneumothorax, pulmonary fibrosis. BUSULFAN dosage: 408 MG. During the same period patient was treated with FLUDARABINE PHOSPHATE, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5163565-0
Health Professional from UNITED STATES reported BUSULFAN problem on Nov 28, 2006. Female patient, child 3 years of age, weighting 29.10 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: electrolyte imbalance, loss of consciousness, stem cell transplant. BUSULFAN dosage: unknown. During the same period patient was treated with CYTOXAN, HEMATOPOETIC PROGENITOR CELLS. Patient died on 11/25/2006.
Busulfan Side Effects Report #5192749-0
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Nov 27, 2006. Female patient, 54 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, liver function test abnormal, venoocclusive liver disease, weight increased. BUSULFAN dosage: 3.2 MG/KG;. During the same period patient was treated with CYCLOSPORINE. Patient died on 11/28/2006.
Busulfan Side Effects Report #5196201-8
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Dec 14, 2006. Male patient, 46 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, liver function test abnormal. BUSULFAN dosage: unknown. Patient died.
Busulfan Side Effects Report #5196208-0
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Dec 14, 2006. Male patient, 49 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, duodenal ulcer, graft versus host disease, renal impairment. BUSULFAN dosage: 3.2 MG/KG;QID;IV. During the same period patient was treated with CYCLOSPORINE. Patient died on 12/05/2006.
Busulfan Side Effects Report #5385414-8
Consumer or non-health professional from JAPAN reported BUSULFAN problem on June 26, 2007. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cerebral haemorrhage, convulsion, mitral valve incompetence, oedema, pneumonia, renal disorder, sepsis, venoocclusive liver disease. BUSULFAN dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.
Busulfan Side Effects Report #5385416-1
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on June 26, 2007. Male patient, 54 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, ascites, blood bilirubin increased, blood lactate dehydrogenase increased, cystitis haemorrhagic, cytomegalovirus antibody positive, cytomegalovirus infection, diarrhoea, graft versus host disease. BUSULFAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE, VALPROATE. Patient died on 12/19/2006.
Busulfan Side Effects Report #5385508-7
Health Professional from JAPAN reported BUSULFAN problem on June 26, 2007. Male patient, 31 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, blood bilirubin increased, blood lactate dehydrogenase increased, cystitis haemorrhagic, thrombotic microangiopathy, viraemia. BUSULFAN dosage: unknown. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5391627-1
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on July 02, 2007. Male patient, 47 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, liver disorder, renal disorder, staphylococcal sepsis, stomatitis, transplant failure. BUSULFAN dosage: 4 ML; QID; IV. During the same period patient was treated with MELPHALAN, CLADRIBINE, PHENYTOIN, LENOGRASTIM, CYCLOSPORINE, METHOTREXATE. Patient recovered.
Busulfan Side Effects Report #5391671-4
Consumer or non-health professional from JAPAN reported BUSULFAN problem on July 03, 2007. Female patient, 48 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute graft versus host disease, anorexia, blood bilirubin increased, bone marrow transplant, cardiac failure, diarrhoea, engraftment syndrome, gastrointestinal haemorrhage. BUSULFAN dosage: 5.3 ML;QID;IV. During the same period patient was treated with HEPARIN, CYCLOPHOSPHAMIDE, PHENYTOIN. Patient recovered.
Busulfan Side Effects Report #5391672-6
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on July 02, 2007. Male patient, 59 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, capillary leak syndrome, cardiac failure, diarrhoea, disseminated intravascular coagulation, gastroenteritis staphylococcal, haemolysis, haemorrhoids, liver disorder. BUSULFAN dosage: 46 MG;QID;IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, HEPARIN. Patient was hospitalized. Patient died on 03/01/2007.
Busulfan Side Effects Report #5391694-5
Consumer or non-health professional from JAPAN reported BUSULFAN problem on July 03, 2007. Female patient, 34 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, diarrhoea, enterococcal sepsis, liver disorder, malaise, nausea. BUSULFAN dosage: 26.8 MG;QD;IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, PHENYTOIN, FILGRASTIM, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfan Side Effects Report #5391695-7
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on July 03, 2007. Male patient, 49 years of age, was diagnosed with stem cell transplant, graft versus host disease and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow transplant rejection, cytomegalovirus infection, diarrhoea, graft complication, hyperbilirubinaemia, malaise, pain in extremity, pseudomembranous colitis. BUSULFAN dosage: 40 ML; QD; IV. During the same period patient was treated with NARTOGRASTIM, TRIMETHYLCETYLAMMONIUM PENTACHLOROPHENATE, CLADRIBINE, PHENYTOIN, LENOGRASTIM, FILGRASTIM, TACROLIMUS, MYCOPHENOLATE MOFETIL. Patient recovered.
Busulfan Side Effects Report #5391696-9
Health Professional from JAPAN reported BUSULFAN problem on July 03, 2007. Female patient, 51 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, blood pressure decreased, bone marrow transplant rejection, cardiac arrest, condition aggravated, diarrhoea, respiratory arrest, sepsis. BUSULFAN dosage: 26.68 ML;QD;IV. During the same period patient was treated with VALPROATE, CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient died on 04/09/2007.
Busulfan Side Effects Report #5391697-0
BUSULFAN problem was reported by a Health Professional from JAPAN on July 03, 2007. Female patient, 50 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, cytomegalovirus infection, diarrhoea, malaise, nausea, pseudomembranous colitis, sepsis, stomatitis. BUSULFAN dosage: 26.4 ML;QD; IV. During the same period patient was treated with METHOTREXATE, FLUDARABINE PHOSPHATE, PHENYTOIN, NEUPOGEN. Patient recovered.
Busulfan Side Effects Report #5392149-4
Consumer or non-health professional from UNITED STATES reported BUSULFAN problem on July 18, 2007. Male patient, weighting 145.5 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, septic shock. BUSULFAN dosage: 1024 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5393398-1
BUSULFAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2007. Male patient, weighting 145.5 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, septic shock. BUSULFAN dosage: 1024 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 07/11/2007.
Busulfan Side Effects Report #5397301-X
Consumer or non-health professional from JAPAN reported BUSULFAN problem on July 06, 2007. Female patient, 40 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, diarrhoea, pharyngeal erythema, sepsis, stomatitis. BUSULFAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, VALPROATE, FILGRASTIM, CYCLOSPORINE. Patient recovered.
Busulfan Side Effects Report #5400046-0
BUSULFAN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 12, 2007. Female patient was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: thrombotic thrombocytopenic purpura. BUSULFAN dosage: unknown. Patient recovered.
Busulfan Side Effects Report #5406731-9
Consumer or non-health professional from JAPAN reported BUSULFAN problem on July 20, 2007. Female patient, 52 years of age, weighting 132.3 lb, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: blood stem cell transplant failure, bone marrow transplant rejection, haemodialysis, renal failure, sepsis, venoocclusive liver disease, weight increased. BUSULFAN dosage: 208 MG. Patient was hospitalized. Patient died on 02/09/2007.
Busulfan Side Effects Report #5406807-6
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Aug 01, 2007. Male patient, child 3 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow transplant rejection, diarrhoea, hyponatraemia, malaise, nausea, vomiting. BUSULFAN dosage: 12 ML;QD;IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5408208-3
Consumer or non-health professional from UNITED STATES reported BUSULFAN problem on Aug 06, 2007. Female patient, weighting 127.9 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, enterocutaneous fistula, febrile neutropenia, metabolic disorder, sepsis, stem cell transplant. BUSULFAN dosage: 640 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died on 07/14/2007.
Busulfan Side Effects Report #5413016-3
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on July 26, 2007. Male patient, 30 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, cerebellar ataxia, cytomegalovirus antigen positive, diarrhoea, gastrointestinal candidiasis, graft versus host disease, herpes zoster, malaise, small intestinal haemorrhage. BUSULFAN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE. Patient recovered.
Busulfan Side Effects Report #5422196-5
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Aug 03, 2007. Female patient, child 7 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant rejection, bronchopulmonary aspergillosis, cystitis haemorrhagic, erythema, flushing, pigmentation disorder, staphylococcal sepsis, swelling, venoocclusive liver disease. BUSULFAN dosage: 20 MG/KG; QD; IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient recovered.
Busulfan Side Effects Report #5422205-3
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Aug 03, 2007. Male patient, 63 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, blood lactate dehydrogenase increased, bone marrow transplant, diarrhoea, febrile neutropenia, gastrointestinal disorder, haemodialysis, haemorrhagic cerebral infarction, liver disorder. BUSULFAN dosage: unknown. Patient recovered.
Busulfan Side Effects Report #5447576-3
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Aug 22, 2007. Male patient, child 10 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, performance status decreased, venoocclusive liver disease. BUSULFAN dosage: 0.8 MG/KG;1X;. Patient died on 05/27/2007.
Busulfan Side Effects Report #5447577-5
BUSULFAN problem was reported by a Health Professional from JAPAN on Aug 22, 2007. Male patient, 55 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, anorexia, cytomegalovirus infection, diarrhoea, malaise, nausea, sepsis, stomatitis. BUSULFAN dosage: 32.8 ML;. During the same period patient was treated with METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5447579-9
Health Professional from JAPAN reported BUSULFAN problem on Aug 22, 2007. Female patient, 21 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, diarrhoea, disseminated intravascular coagulation, malaise, multi-organ failure, nausea, neutropenia, staphylococcal sepsis, stem cell transplant. BUSULFAN dosage: 6.2 ML;BID;IV; 6.2 ML;QID;IV; 6.2 ML;X1;IV. During the same period patient was treated with PHENYTOIN, CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient died on 05/05/2007.
Busulfan Side Effects Report #5466145-2
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Sept 10, 2007. Male patient, 45 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, diarrhoea, enterococcal sepsis, pneumonia parainfluenzae viral. BUSULFAN dosage: 28 ML; QD; IV. During the same period patient was treated with VALPROATE, FLUDARABINE PHOSPHATE, LENOGRASTIM, TACROLIMUS, MELPHALAN. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5466146-4
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Sept 10, 2007. Female patient, 56 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, diarrhoea, haemodialysis, pneumonia, renal failure acute, sepsis, stomatitis. BUSULFAN dosage: 26.4 ML; QD; IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, NEUPOGEN, VALPROATE, METHOTREXATE, TACROLIMUS, CYCLOSPORINE. Patient died on 06/15/2007.
Busulfan Side Effects Report #5466154-3
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Sept 10, 2007. Male patient, 20 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, diarrhoea, gastrointestinal perforation, stress ulcer, thrombotic microangiopathy, upper gastrointestinal haemorrhage. BUSULFAN dosage: 31.2 ML;QD;IV; 41.6 ML;QD;IV; 10.4 ML;QD;IV. During the same period patient was treated with NEUPOGEN, VALPROATE, CYCLOPHOSPHAMIDE, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5466200-7
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Sept 10, 2007. Female patient, 48 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, blood bilirubin increased, bone marrow transplant, cardiac failure, engraftment syndrome, gastrointestinal haemorrhage, hepatic function abnormal, hypernatraemia, interstitial lung disease. BUSULFAN dosage: 5.3 ML;QID;IV. During the same period patient was treated with HEPARIN, CYCLOPHOSPHAMIDE, PHENYTOIN. Patient was hospitalized. Patient died.
Busulfan Side Effects Report #5466201-9
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Sept 10, 2007. Female patient, 34 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: enterococcal infection, histiocytosis haematophagic, sepsis, transplant failure. BUSULFAN dosage: 24 ML;QD;IV; ;IV. During the same period patient was treated with FLUDARABINE PHOSPHATE, VALPROATE, NEUPOGEN, TACROLIMUS. Patient died on 06/12/2007.
Showing 1-50 of 112 Next >